Silencing of GPR81 in hormone receptor positive breast tumor cells reduced the expression of specifically MCT1 but not of MCT2 or MCT4, resulting in decreased lactate uptake, extracellular acidification, and inhibition of tumor cell proliferation and survival (69). Here, SLC16A3 is linked to breast neoplasm.